Roundtable-Mergers & Acquisitions
Jun. 1, 2014
Mergers & Acquisitions
An update with Foley & Lardner; Morrison & Foerster; and Shearman & Sterling
Market watchers view mergers and acquisitions as an economic yardstick. After several years of modest volumes, we've already seen substantial M&A activity in 2014 across industries including biotech, pharmaceuticals, and technology. Has the market rediscovered its mojo? Our panel from Silicon Valley and San Francisco discusses the forces driving the recent upturn in deal volume, as well as talking about trends in shareholder activism, and current patterns in pre-Series A tech ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In